Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Shohdy KS"'
Autor:
Shohdy KS; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Pillai M; The Christie NHS Foundation Trust, Manchester, UK., Abbas KS; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Allison J; The Christie NHS Foundation Trust, Manchester, UK., Waddell T; The Christie NHS Foundation Trust, Manchester, UK., Darlington E; The Christie NHS Foundation Trust, Manchester, UK., Mohammad S; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Hood S; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Atkinson S; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Simpson K; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Morgan D; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Nathan P; Mount Vernon Cancer Centre - East and North Herts NHS Trust, Northwood, Middlesex, UK., Kilgour E; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Dive C; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, Manchester, UK., Thistlethwaite F; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK.
Publikováno v:
Immuno-oncology technology [Immunooncol Technol] 2024 Mar 18; Vol. 22, pp. 100712. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).
Autor:
Ohara K; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Rendeiro AF; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14 AKH BT 25.3, 1090, Vienna, Austria., Bhinder B; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA., Eng KW; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA., Ravichandran H; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Nguyen D; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, 10065, USA., Pisapia D; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Vosoughi A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Fernandez E; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA., Shohdy KS; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, 10065, USA., Manohar J; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Beg S; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Wilkes D; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Robinson BD; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Khani F; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA., Bareja R; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA., Tagawa ST; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, 10065, USA.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, NY, 10065, USA., Ouseph MM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA., Sboner A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA., Elemento O; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10021, USA.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, NY, 10065, USA., Faltas BM; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA. bmf9003@med.cornell.edu.; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, 10065, USA. bmf9003@med.cornell.edu.; Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, New York, NY, 10065, USA. bmf9003@med.cornell.edu.; Departments of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, 10065, USA. bmf9003@med.cornell.edu., Mosquera JM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10065, USA. jmm9018@med.cornell.edu.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA. jmm9018@med.cornell.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Mar 18; Vol. 15 (1), pp. 2009. Date of Electronic Publication: 2024 Mar 18.
Autor:
Abdeltwab RM; Department of Clinical Oncology, Cairo University, Cairo, Egypt., Yacoub E; Department of Clinical Oncology, Cairo University, Cairo, Egypt., Rashad AH; Department of Clinical Oncology, Cairo University, Cairo, Egypt., Shohdy KS; School of Cancer Sciences, The University of Glasgow, Glasgow, UK.
Publikováno v:
Bladder cancer (Amsterdam, Netherlands) [Bladder Cancer] 2023 Dec 13; Vol. 9 (4), pp. 313-322. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).
Autor:
Azim HA; Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.; Medical Oncology Unit, Cairo Oncology Center, Cairo, Egypt., Loutfy SA; Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.; Nanotechnology Research Center, BUE, Cairo, Egypt., Azim HA Jr; Medical Oncology Unit, Cairo Oncology Center, Cairo, Egypt., Kamal NS; Medical Oncology Unit, Cairo Oncology Center, Cairo, Egypt., Abdel Fattah NF; Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Elberry MH; Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Abdelaziz MR; Oncology Medical Manager, Pfizer, Cairo, Egypt., Abdelsalam M; Medical Oncology Unit, Cairo Oncology Center, Cairo, Egypt., Aziz M; Clinical Research Unit, Cairo Oncology Center, Cairo, Egypt., Shohdy KS; Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Kassem L; Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt. loay.kassem@cairocure.com.; Medical Oncology Unit, Cairo Oncology Center, Cairo, Egypt. loay.kassem@cairocure.com.
Publikováno v:
Oncology and therapy [Oncol Ther] 2023 Dec; Vol. 11 (4), pp. 445-459. Date of Electronic Publication: 2023 Sep 20.
Autor:
Shohdy KS; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.; Department of Clinical Oncology Cairo University Cairo Egypt., Pillai M; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK., Guest R; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK., Rothwell D; Cancer Research UK Manchester Institute Cancer Biomarker Centre The University of Manchester Manchester UK., Kirillova N; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK., Chow S; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK., Gilham D; Clinical and Experimental Immunotherapy Group Institute of Cancer Sciences, Manchester Academic Healthcare Science Centre Manchester UK., Thistlethwaite F; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK., Hawkins R; Division of Cancer Sciences The University of Manchester and The Christie NHS Foundation Trust Manchester UK.; Cellular Therapeutics Limited Manchester UK.
Publikováno v:
EJHaem [EJHaem] 2023 Jun 24; Vol. 4 (3), pp. 882-885. Date of Electronic Publication: 2023 Jun 24 (Print Publication: 2023).
Autor:
Owen K; ATMP Master Programme, The University of Manchester, Manchester, UK., Ghaly R; Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA., Shohdy KS; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Thistlethwaite F; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK. fiona.thistlethwaite@nhs.net.; Division of Cancer Sciences, The University of Manchester, Manchester, UK. fiona.thistlethwaite@nhs.net.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Apr; Vol. 72 (4), pp. 805-814. Date of Electronic Publication: 2022 Oct 31.
Autor:
Azim HA; Clinical Oncology Department, Cairo University, Cairo, Egypt., Shohdy KS; Clinical Oncology Department, Cairo University, Cairo, Egypt.; Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, United Kingdom., Elghazawy H; Clinical Oncology Department, Ain Shams University, Cairo, Egypt., Salib MM; Clinical Oncology Department, Cairo University, Cairo, Egypt., Almeldin D; Clinical Oncology Department, Cairo University, Cairo, Egypt., Kassem L; Clinical Oncology Department, Cairo University, Cairo, Egypt.
Publikováno v:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2022 Dec; Vol. 27 (8), pp. 764-772. Date of Electronic Publication: 2022 Aug 22.
Autor:
Shohdy KS; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Villamar DM; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Cao Y; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Trieu J; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Price KS; Guardant Health, Inc, Redwood City, CA, USA., Nagy R; Guardant Health, Inc, Redwood City, CA, USA., Tagawa ST; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Molina AM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Sternberg CN; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Nanus DM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Mosquera JM; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Elemento O; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Sonpavde GP; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Grivas P; Department of Medical Oncology, University of Washington, Seattle, WA, USA., Vogelzang NJ; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. nicholas.vogelzang@usoncology.com., Faltas BM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA. bmf9003@med.cornell.edu.; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. bmf9003@med.cornell.edu.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. bmf9003@med.cornell.edu.; Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, USA. bmf9003@med.cornell.edu.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Feb; Vol. 126 (3), pp. 430-439. Date of Electronic Publication: 2022 Jan 19.
Autor:
Shohdy KS; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt. shohdyks@cu.edu.eg.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. shohdyks@cu.edu.eg., Almeldin DS; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Fekry MA; Faculty of Pharmacy, Modern Sciences and Arts (MSA) University, Cairo, Egypt., Ismail MA; Department of Obstetrics and Gynecology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., AboElmaaref NA; Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., ElSadany EG; Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Hamza BM; Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., El-Shorbagy FH; Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Ali AS; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Attia H; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Kassem L; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Publikováno v:
Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2021 Dec 14; Vol. 33 (1), pp. 39. Date of Electronic Publication: 2021 Dec 14.
Autor:
Shohdy KS; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Almeldin DS; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Ghaly R; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Kassem L; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt., Pagani O; Interdisciplinary Cancer Service, Hopital Riviera-Chablais, Rennaz, Geneva University Hospitals, Switzerland.
Publikováno v:
Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2021 Oct 26; Vol. 5 (1), pp. 7-9. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2022).